高密度脂蛋白在脓毒症中的作用分析

doi:10.3969/j.issn.1002-1949.2018.05.016

摘要
图/表
参考文献(36)
相关文章 (15)

全文: PDF (3089 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要脓毒症是住院患者死亡的主要原因之一，对于复杂的病理机制的认识为更好的诊断、治疗及预后提供可能。因高密度脂蛋白（HDL）具有抗炎、抗氧化、控制血糖等多种功能，在脓毒症中HDL作为新的线索被广泛引起关注。HDL在一定程度上参与脓毒症的发生、发展及演变。目前,在脓毒症中HDL的具体作用需通过进一步的研究加以验证。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	魏敏
	周荣

关键词 ：高密度脂蛋白（HDL）, 脓毒症, 功能, 分析

通讯作者: 周荣（1964-），女，硕士，主任医师，硕士生导师，教授，E-mail：zhourong0204@163.com。

作者简介: 魏敏（1990-），女，硕士研究生，住院医师，E-mail：1367354346@qq.com。

引用本文:

魏敏，周荣. 高密度脂蛋白在脓毒症中的作用分析[J]. 中国急救医学, 2018, 38(5): 451-.
Wei Min, Zhou Rong. The evaluation of HDL during eepsis. Chinese Journal of Critical Care Medicine, 2018, 38(5): 451-.

链接本文:

http://www.cnemergency.org.cn/CN/10.3969/j.issn.1002-1949.2018.05.016 或 http://www.cnemergency.org.cn/CN/Y2018/V38/I5/451

［1］Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012［J］. Intensive Care Med, 2013, 39(2):165-228. ［2］van Leeuwen HJ, Heezius EC, Dallinga GM, et al. Lipoprotein metabolism in patients with severe sepsis［J］. Crit Care Med, 2003, 31(5):1359-1366. ［3］Chien JY, Jerng JS, Yu CJ, et al. Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis［J］. Crit Care Med, 2005, 33(8):1688-1693.  ［4］Lee SH, Park MS, Park BH, et al. Prognostic implications of serum lipid metabolism over time during sepsis［J］. Biomed Res Int, 2015, 2015:789 298. ［5］Angus DC, van der Poll T. Severe sepsis and septic shock［J］. N Engl J Med, 2013, 369(9):840-851. ［6］Cooney MT, Dudina A, De Bacquer D, et al. HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of risk［J］.Atherosclerosis, 2009, 206(2):611-616. ［7］Peshavariya H, Dusting GJ, Di Bartolo B, et al. Reconstituted high-density lipoprotein suppresses leukocyte NADPH oxidase activation by disrupting lipid rafts［J］. Free Radic Res, 2009, 43（8）:772-782. ［8］Nicholls SJ, Cutri B, Worthley SG, et al. Impact of short-term administration of high-density lipoproteins and atorvastatin on atherosclerosis in rabbits［J］. Arterioscler Thromb Vasc Biol, 2005, 25（11）:2416-2421.［9］Karavia EA, Hatziri A, Kalogeropoulou C, et al.Deficiency in apolipoprotein A-I ablatesthe pharmacological effects of metformin on plasma glucose homeostasisand hepatic lipid deposition［J］. Eur J Pharmacol, 2015, 766: 76-85. ［10］刘皓,刘秉文.载脂蛋白C研究进展［J］.中国动脉硬化杂志, 2002, 10（1）:76-80. ［11］王磊,宿红艳,明永飞,等.载脂蛋白D的结构、功能及临床应用［J］.细胞生物学杂志, 2008， 30(1):50-54. ［12］Saito H, Dhanasekaran P, Baldwin F, et al. Lipid binding-induced conformational change in human apolipoprotein E. Evidence for two lipid-bound states on spherical particles［ J］. J Biol Chem, 2001, 276(44): 40949-40954. ［13］Singh K, Chaturvedi R, Asim M, et al. The apolipoprotein E-mimetic peptide COG112 inhibits the inflammatory response to Citrobacter rodentiumin colonic epithelial cells by preventing NF-kappa B activation［ J］. J Biol Chem, 2008, 283 (24): 16752-16761. ［14］van den Elzen P,Garg S, León L, et al. Apolipoprotein-mediated pathways of lipid antigen presentation［J］. Nature, 2005, 437(7060): 906-910. ［15］Murphy AJ, Akhtari M, Tolani S, et al.ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice［J］. J Clin Invest, 2011, 121（10）:4138-4149.［16］Lagor WR, Brown RJ, Toh SA, et al. Overexpression of apolipoprotein F reduces HDL cholesterol levels in vivo［J］. Arterioscler Thromb Vasc Biol, 2009, 29(1): 40-46. ［17］Lagor WR, Fields DW, Khetarpal SA, et al. The effects of apolipoprotein F deficiency on high density lipoprotein cholesterol metabolism in mice［J］. PLoS One, 2012, 7(2): e31 616. ［18］Deakin JE, Papenfuss AT, Belov K, et al. Evolution and comparative analysis of the MHC Class Ⅲ inflammatory region［ J］. BMC Genomics, 2006, 7:281. ［19］Binkowska AM, Michalak G, Slotwinski R. Current views on the mechanisms of immune responses to trauma and infection［J］. Cent Eur J Immunol, 2015, 40(2):206-216. ［20］Kumaraswamy SB, Linder A, Akesson P,et al. Decreased plasma concentrations of apolipoproteinMin sepsis and systemic inflammatory response syndromes［J］. Crit Care, 2012, 16（2）:R60. ［21］Wolfrum C, Poy MN, Stoffel M. ApolipoproteinMis required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis［J］. Nat Med, 2005, 11（4）:418-422. ［22］Filippas-Ntekouan S, Liberopoulos E, Elisaf M. Lipid testing in infectious diseases: possible role in diagnosis and prognosis［J］. Infection, 2017, 45(5): 575-588. ［23］夏晓丹,唐朝克.失功能性HDL研究进展［J］.生理科学进展, 2016, 47(5):381-385. ［24］Tan Y，Liu TR，Hu SW ，et al．Acute coronary syndrome remodels the protein cargo and functions of high density lipoprotein subfractions［J］．P1oS one， 2014， 9(4)：e94 264． ［25］Tolle M, Huang T, Schuchardt M, et al. High-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid A［J］. Cardiovasc Res, 2012, 94(1): 154-162. ［26］钟建开,谭迎,陈盈文,等.同型半胱氨酸对高密度脂蛋白逆转运和抗氧化功能的影响［J］.中华老年心脑血管病杂志, 2016, 18(3):233-236. ［27］Gordon SM, McKenzie B, Kemeh G, et al. Rosuvastatin Alters the Proteome of High Density Lipoproteins: Generation of alpha-1-antitrypsin Enriched Particles with Anti-inflammatory Properties［J］. Mol Cell Proteomics, 2015， 14(12): 3247-3257. ［28］Deckert V, Lemaire S, Ripoll PJ, et al. Recombinant human plasma phospholipid transfer protein (PLTP)to prevent bacterial growth and to treat sepsis［J］. Sci Rep, 2017, 7(1): 3053. ［29］Vaisar T, Tang C, Babenko I, et al. Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity［J］. J Lipid Res, 2015， 56(8): 1519-1530. ［30］Recalde D, Ostos MA, Badell E, et al. Human apolipoprotein A-IV reduces secretion of proinflammatory cytokines and atherosclerotic effects of a chronic infection mimicked by lipopolysaccharide［J］. Arterioscler Thromb Vasc Biol, 2004， 24(4): 756-761. ［31］Stan S, Delvin E, Lambert M, et al. Apo A-IV: an update on regulation and physiologic functions［J］. Biochim Biophys Acta, 2003， 1631(2): 177-187. ［32］Kohan AB, Wang F, Lo CM, et al. ApoA-Ⅳ: current and emerging roles in intestinal lipid metabolism, glucose homeostasis, and satiety［J］. Am J Physiol Gastrointest Liver Physiol, 2015， 308(6): G472-481. ［33］Tran-Dinh A, Diallo D, Delbosc S, et al. HDL and endothelial protection［J］. Br J Pharmacol， 2013， 169(3):493-511. ［34］Zhang X, Wang L, Chen B. Recombinant HDL (Milano)protects endotoxin-challenged rats from multiple organ injury and dysfunction［J］. Biol Chem， 2015， 396(1):53-60. ［35］Tanaka S, Labreuche J, Drumez E, et al. Low HDL levels in sepsis versus trauma patients in intensive care unit［J］. Ann Intensive Care, 2017， 7(1): 60. ［36］Cirstea M, Walley KR, Russell JA, et al.Decreased high-density lipoprotein cholesterol level is an early prognostic marker for organ dysfunction and death in patients with suspected sepsis［J］. J Crit Care， 2017， 38:289-294.